Phase 2 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People diagnosed with a type of lung cancer called lung adenocarcinoma that can be removed with surgery, at a stage between IIA and IIIA.
- People whose lung cancer has a specific genetic change known as an EGFR sensitizing mutation (either Ex19del or L858R).
- People whose treatment plan includes a drug called osimertinib given before surgery, and whose doctors expect them to live for more than 3 months.
- People with a good general level of physical functioning, rated 0 or 1 on a standard medical scale (confirm with trial site).
- People whose main lung tumour measures at least 1 cm across.
- People who have taken aspirin in the past or are currently taking aspirin are permitted to join.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People currently taking other blood-thinning (anticoagulant) medications.
- People who have already received systemic (whole-body) treatment for their lung cancer.
- People whose lung cancer has other specific genetic changes, such as ALK, ROS1, MET14 exon skipping, BRAF, or RET mutations, among others.
- People for whom the use of osimertinib or aspirin is medically not advised.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-23-68757791
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Major pathologic response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.